SCHEMBL23867578

SCHEMBL23867578

Cc1cc(Nc2ccc(C(=O)Nc3c[nH]c4ccccc34)cc2)nc(N2CCN(CCO)CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.48
▸ CCNE1 P24864 5/20 0.46
▸ CDK2 P24941 5/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ HTR2A P28223 7/20 0.43
▸ DRD3 P35462 2/20 0.42
▸ SRC P12931 2/20 0.41
▸ MYC P01106 1/20 0.40
▸ DNMT1 P26358 1/20 0.40
▸ MAP2K3 P46734 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.40
▸ EHMT1 Q9H9B1 1/20 0.40
▸ DNMT3B Q9UBC3 1/20 0.40
▸ DNMT3L Q9UJW3 1/20 0.40
▸ DNMT3A Q9Y6K1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867509 0.89 CCNE1 (0.50) CCNE1CDK2KDM4EALDH1A1LMNA
SCHEMBL23867521 0.88 HTR1A (0.50) HTR1ACCNE1CDK2KDM4EALDH1A1
SCHEMBL23867572 0.87 ACHE (0.48) CCNE1CDK2LMNAHTR2ADRD3
SCHEMBL23867577 0.84 HTR2A (0.51) HTR2ADRD3SRC
SCHEMBL30165658 0.77 HRH3 (0.53) CCNE1CDK2KDM4EALDH1A1LMNA
SCHEMBL23859943 0.77 HRH3 (0.53) CCNE1CDK2KDM4EALDH1A1LMNA
SCHEMBL23867485 0.76 HCRTR1 (0.46) HTR1AKDM4EALDH1A1LMNAHPGD
SCHEMBL23867575 0.76 PYGM (0.51) CCNE1CDK2KDM4EALDH1A1LMNA
SCHEMBL23867512 0.74 ACHE (0.50) CCNE1CDK2LMNAHTR2ADRD3
SCHEMBL23867479 0.72 POLB (0.49) KDM4EALDH1A1LMNAHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback